If you want to go the extra mile, you could try red-light therapy and hyperbaric chambers, which have limited evidence but may be worth a shot
Approximately one of every 300 people in the United States has overt hypothyroidism, and about one of every 23 has subclinical hypothyroidism, though not all cases are symptomatic
Novo Nordisk, Pfizer and other big pharma companies have just taken [the hormone] GLP-1 itself, and spent 20 years stabilising the peptide, making it druggable, so its not broken down [in the body], explains John Unitt, vice president of immunology and inflammation drug discovery at Sygnature Discovery in Nottinghamshire, UK, and a GPCR drug discovery expert
Broader Tissue Coverage: While BPC-157 shows particular affinity for GI and connective tissues, TB-500 demonstrates effects across a wider range of tissue types